Autoimmune Cytopenias in Patients with Chronic Lymphocytic Leukaemia Treated with Ibrutinib in Routine Clinical Practice at an Academic Medical Centre

類似資料

• The efficacy of ibrutinib in the treatment of Richter syndrome
  著者:: Tsang, Mazie, 等
  出版事項: (2015)
• Rapid disease progression following discontinuation of ibrutinib in patients with chronic lymphocytic leukemia treated in routine clinical practice
  著者:: Hampel, Paul J., 等
  出版事項: (2019)
• Pharmacovigilance during Ibrutinib Therapy for Chronic Lymphocytic Leukemia (CLL) / Small Lymphocytic Lymphoma (SLL) in Routine Clinical Practice
  著者:: Finnes, Heidi D., 等
  出版事項: (2016)
• The impact of dose modification and temporary interruption of ibrutinib on outcomes of chronic lymphocytic leukemia patients in routine clinical practice
  著者:: Parikh, Sameer A., 等
  出版事項: (2020)
• Chronic lymphocytic leukemia cells from ibrutinib treated patients are sensitive to Axl receptor tyrosine kinase inhibitor therapy
  著者:: Sinha, Sutapa, 等
  出版事項: (2018)